Skip to search formSkip to main contentSkip to account menu

Actilyse

Known as: Lysatec rt PA, Lysatec rt-PA, Lysatec rtPA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ionic cross-linking of water-soluble chitosan with sodium tripolyphosphate in the presence of recombinant tissue plasminogen… 
Review
2015
Review
2015
Background and Purpose— There is controversy on the relationship of the type of atrial fibrillation (AF) to stroke. Although… 
Highly Cited
2014
Highly Cited
2014
Thrombotic disease is extremely harmful to human health, but early detection and treatment can help improve prognoses and reduce… 
Review
2012
Review
2012
BackgroundCerebrovascular disease represents a major source of global mortality and morbidity. Imaging examinations play a… 
2010
2010
Highly Cited
2003
Highly Cited
2003
Background and Purpose— Recombinant tissue plasminogen activator (rtPA; Actilyse) is not as widely used in clinical practice as… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND AND PURPOSE We chose to evaluate the safety and efficacy of combined intrathrombus rtPA and intravenous heparin in… 
Highly Cited
1994
Highly Cited
1994
BACKGROUND The early establishment of infarct artery reperfusion by intravenous thrombolytic therapy has improved survival after…